Eprosartan Teva 300 mg Film-coated Tablets Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

eprosartan teva 300 mg film-coated tablets

teva b.v. - eprosartan mesylate - film-coated tablet - 300 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Eprosartan Teva 400 mg Film-coated Tablets Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

eprosartan teva 400 mg film-coated tablets

teva b.v. - eprosartan mesylate - film-coated tablet - 400 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

Eprosartan Teva 600 mg Film-coated Tablets Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

eprosartan teva 600 mg film-coated tablets

teva b.v. - eprosartan mesylate - film-coated tablet - 600 milligram(s) - angiotensin ii antagonists, plain; eprosartan - angiotensin ii antagonists, plain. - it is indicated in adults for the treatment of essential hypertension.

OLMESARTAN MEDOXOMIL Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil

glenmark pharmaceuticals europe limited - olmesartan medoxomil - film coated tablet - 10 milligram - angiotensin ii antagonists, plain - angiotensin ii antagonists - treatment of essential hypertension in adults and treatment of hypertension in children and adolescents from 6 to less than 18 years of age

OLMESARTAN MEDOXOMIL Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil

glenmark pharmaceuticals europe limited - olmesartan medoxomil - film coated tablet - 20 milligram - angiotensin ii antagonists, plain - angiotensin ii antagonists - treatment of essential hypertension in adults and treatment of hypertension in children and adolescents from 6 to less than 18 years of age

OLMESARTAN MEDOXOMIL Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil

glenmark pharmaceuticals europe limited - olmesartan medoxomil - film coated tablet - 40 milligram - angiotensin ii antagonists, plain - angiotensin ii antagonists - treatment of essential hypertension in adults and treatment of hypertension in children and adolescents from 6 to less than 18 years of age.

Lotanos Comp 50 mg/12.5 mg film-coated tablets Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

lotanos comp 50 mg/12.5 mg film-coated tablets

rowa pharmaceuticals limited - losartan potassium; hydrochlorothiazide - film-coated tablet - 50 /12.5 milligram(s) - angiotensin ii antagonists and diuretics; losartan and diuretics - angiotensin ii antagonists and diuretics - it is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on hydrochlorothiazide or losartan monotherapy

Lotanos Comp 100 mg/25 mg film-coated tablets Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

lotanos comp 100 mg/25 mg film-coated tablets

rowa pharmaceuticals limited - losartan potassium; hydrochlorothiazide - film-coated tablet - 100 /25 milligram(s) - angiotensin ii antagonists and diuretics; losartan and diuretics - angiotensin ii antagonists and diuretics - for the treatment of essential hypertension

TEVETEN 400 Milligram Film Coated Tablet Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

teveten 400 milligram film coated tablet

bgp products ltd - eprosartan mesylate - film coated tablet - 400 milligram - angiotensin ii antagonists, plain - angiotensin-ii antagonists, plain c - eprosartan is indicated for the treatment of essential hypertension.

TEVETEN 600 Milligram Film Coated Tablet Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

teveten 600 milligram film coated tablet

bgp products ltd - eprosartan mesylate - film coated tablet - 600 milligram - angiotensin ii antagonists, plain - angiotensin-ii antagonists, plain c - eprosartan is indicated for the treatment of essential hypertension